Gregory L Beatty

15PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 08, 2025
Nonredundant Immune Checkpoints Direct Therapeutic Resistance to Chemoimmunotherapy in Pancreatic Ductal Adenocarcinoma.

Meredith L Stone, Veronica M Herrera, Yan Li

|Mar 21, 2025
Facts and Hopes of CD40 Agonists in Cancer Immunotherapy.

John C McVey, Gregory L Beatty

|Nov 08, 2024
Exogenous or in situ vaccination to trigger clinical responses in pancreatic cancer.

Gregory L Beatty, Elizabeth M Jaffee

|May 02, 2024
Multiplexed Imaging Mass Cytometry Analysis Characterizes the Vascular Niche in Pancreatic Cancer.

Jonathan H Sussman, Nathalia Kim, Samantha B Kemp

|Apr 19, 2024
Hepatocytes coordinate immune evasion in cancer via release of serum amyloid A proteins.

Meredith L Stone, Jesse Lee, Jae W Lee

Pageof 3